MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
207.63
-0.15
-0.07%
After Hours: 207.86 +0.23 +0.11% 19:59 12/26 EST
OPEN
207.53
PREV CLOSE
207.78
HIGH
208.04
LOW
206.71
VOLUME
2.32M
TURNOVER
--
52 WEEK HIGH
215.19
52 WEEK LOW
136.50
MARKET CAP
500.24B
P/E (TTM)
20.04
1D
5D
1M
3M
1Y
5Y
1D
Notable healthcare headlines for the week: J&J, Pfizer, and Novo Nordisk in focus
Seeking Alpha · 11h ago
Best Dividend Kings: December 2025
Seeking Alpha · 13h ago
enGene Holdings: A Potential Oncology Entrant
Seeking Alpha · 2d ago
Can Amgen Sustain Its Rally In 2026
Seeking Alpha · 2d ago
Johnson & Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss
Benzinga · 2d ago
J&J Atopic Dermatitis Study Misses Efficacy Standard
Dow Jones · 2d ago
J&J eczema therapy trails expectations in mid-stage trial
Seeking Alpha · 2d ago
Can J&J's Pipeline Progress in 2025 Aid Long-Term Growth?
NASDAQ · 2d ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.